McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of McKesson Corporation (NYSE:MCK) have received a consensus rating of “Moderate Buy” from the seventeen analysts that are presently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $960.9333.

Several equities analysts have commented on the stock. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. TD Cowen boosted their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Raymond James Financial set a $970.00 target price on shares of McKesson in a report on Thursday, March 5th. Leerink Partners reaffirmed an “outperform” rating and issued a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Finally, Barclays boosted their price target on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th.

Insiders Place Their Bets

In other McKesson news, Director Maria Martinez sold 349 shares of McKesson stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the transaction, the director owned 301 shares of the company’s stock, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 3,868 shares of company stock worth $3,743,820. Corporate insiders own 0.08% of the company’s stock.

Hedge Funds Weigh In On McKesson

A number of hedge funds have recently modified their holdings of MCK. University of Texas Texas AM Investment Management Co. purchased a new stake in McKesson in the 4th quarter valued at $25,000. Swiss RE Ltd. purchased a new position in McKesson during the 4th quarter worth $26,000. GGM Financials LLC acquired a new position in McKesson in the third quarter valued at $25,000. State of Wyoming purchased a new stake in shares of McKesson in the second quarter valued at about $29,000. Finally, Hopwood Financial Services Inc. acquired a new stake in shares of McKesson during the third quarter worth about $31,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Price Performance

Shares of NYSE MCK opened at $888.28 on Friday. The business has a 50-day moving average of $903.68 and a two-hundred day moving average of $833.49. The company has a market capitalization of $108.81 billion, a price-to-earnings ratio of 25.55, a price-to-earnings-growth ratio of 1.43 and a beta of 0.38. McKesson has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the prior year, the business posted $8.03 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts expect that McKesson will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.